Geriatric Medicine Doctors in Jamaica, NY Accepting Medicare

8 Geriatric Medicine doctors found. Showing 1 - 8

Dr. Mohammad Mahmudur Rahman, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 17012 Highland Ave, Unit 101, Jamaica, NY 11432 Phone: 718-864-8882

Dr. Zumaira Fatima, M.D., Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 15211 89th Ave, Jamaica, NY 11432 Phone: 718-558-2000

Sakina Ouedraogo Tall, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8268 164th St, Jamaica, NY 11432 Phone: 718-883-4343    Fax: 718-883-6330

Dr. Mohammad Quamruzzaman, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 87-25, Homelawn Street, 1st Floor, Jamaica, NY 11432 Phone: 718-206-1117    Fax: 718-383-8047

Dr. Muhammad Hasnain Noor, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8720, 175th St, Apt 3a, Jamaica, NY 11432 Phone: 718-291-3062

Surendrakumar Mahadevia, Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 9028 Van Wyck Expy, Jamaica, NY 11418 Phone: 718-206-5300

Clifford Frank Feiner, DO Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 11402 Guy R Brewer Blvd, Jamaica, NY 11434 Phone: 718-883-6626    Fax: 718-883-6193

Dr. Malgorzata Anna Lange, MD Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 8268 164th St, Jamaica, NY 11432 Phone: 718-883-3225    Fax: 718-883-6193

News Archive

XenoPort files SPA with FDA for arbaclofen placarbil Phase 3 trial in multiple sclerosis

XenoPort, Inc. announced today that it had reached agreement with the U.S. Food and Drug Administration on a Special Protocol Assessment for a pivotal Phase 3 clinical trial of arbaclofen placarbil, previously known as XP19986, as a potential treatment of spasticity in multiple sclerosis patients.

Price of snakebite drug is sky high, but new competitor unlikely to lower costs

Dr. Steven Curry has treated patients with snakebites since the 1980s — long enough to remember when the treatment represented its own form of misery.

Ludwig researchers establish proof of concept for new approach to drug design

Exploring the fundamental mechanism by which a cell-surface receptor transmits its signal, an international team of Ludwig researchers and their colleagues has established proof of concept for an entirely new approach to drug design. They report that a class of synthetic molecules known as diabodies can, from outside the cell, latch onto a target receptor and manipulate it in such a manner as to induce distinct and varying effects within cells and tissues.

Schizophrenia: A major public health problem

Schizophrenia is a major public health problem. Affecting almost 1% of the world's population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease. Elements of the disease are present from birth, other aspects emerge during developmental years, and the illness becomes fully expressed in early adulthood with long-lasting implications for most patients.

Read more Medical News

› Verified 3 days ago